Pilot dose–response trial of i.v. ketamine in treatment-resistant depression

Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial

(2013) James W. Murrough et al.   AMERICAN JOURNAL OF PSYCHIATRY

Ketamine as a new treatment for depression: A review of its efficacy and adverse effects

(2013) Natalie Katalinic et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial

(2012) Carlos A. Zarate et al.   BIOLOGICAL PSYCHIATRY

A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department

(2011) Gregory Luke Larkin et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression

(2011) Lobna Ibrahim et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [1H]-MRS

(2011) Gerald W. Valentine et al.   PSYCHIATRY RESEARCH-NEUROIMAGING

A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression

(2010) Nancy Diazgranados et al.   ARCHIVES OF GENERAL PSYCHIATRY

The Gap Between Clinical Trials and Clinical Practice: The Use of Pragmatic Clinical Trials to Inform Regulatory Decision Making

(2009) E P Brass   CLINICAL PHARMACOLOGY & THERAPEUTICS

A Multidimensional Tool to Quantify Treatment Resistance in Depression

(2009) Abebaw Fekadu et al.   JOURNAL OF CLINICAL PSYCHIATRY